GWGuiyu Wang

Guiyu Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guiyu Wang has a total of 140 co-authors. Here are the top co-authors by number of shared publications:

  • Chunlin Wang

    Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China

    9 shared publications
  • Weiyuan Zhang

    Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin City, China

    8 shared publications
  • Hao Zhang

    Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China

    7 shared publications
  • Ziming Yuan

    Department of Colorectal Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China

    7 shared publications
  • Hanqing Hu

    Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin City, China

    6 shared publications
  • Jun Xiang

    Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China

    6 shared publications

Latest Publications

  • Open Access

    Peritumoral Malignant Cellular Foci Performs Better Than Tumor Budding and Poorly Differentiated Cluster in Risk Stratification of Lymph Node Metastasis in pT1 Colorectal Cancer

    by Chaofeng Yuan, Chao Wang, Jiajun Lai, Jiannan Huang, Jiewei Chen, Wenfei Wu, Jingyun Yang, Zeji Yang, Xuemei Liang, Qi Zhang, et al.

    As biomarkers separated by the arbitrary 5-tumor-cell cutoff at the tumor invasive front, tumor budding (TB) and poorly differentiated clusters (PDC) are recognized as high-risk factors for lymph node metastasis (LNM) in pT1 colorectal cancer (CRC). Nonetheless, relevant findings remain inconsistent. Furthermore, the association between the tumor invasive front biomarker and D3 LNM in pT1 CRC remains unknown. To identify a biomarker that captures the full morphologic spectrum and eliminates the need for such cutoffs at the tumor invasive front for predicting LNM, particularly D3 LNM, in pT1 CRC, we defined peritumoral malignant cellular foci (PMCF) as nonglandular foci composed of ≥1 tumor cell at the tumor invasive front. After enrolling 2611 endoscopically or surgically resected pT1 CRC patients from 6 high-volume Chinese institutions, we found that neither TB nor PDC exhibited a consistent independent association with LNM across the training and validation cohorts. In contrast, PMCF emerged as an independent risk factor with superior risk stratification of LNM in both cohorts ( P P P <0.05). In conclusion, PMCF not only suggests additional radical surgery after endoscopic resection in pT1 CRC, but may also indicate D3 lymph node dissection. PMCF provides an evidence-based rationale to optimize surgical decision-making in pT1 CRC.

  • Open Access

    Synchronous multiple primary colorectal cancer with discordant RAS status between primary lesions: a case report in an elderly patient

    by Junting Guan, Jiyuan Chen, Shengqi Pan, Qi Li, Guiyu Wang, Qingchao Tang

    Background: Synchronous multiple primary colorectal cancer (SMPCRC) is rare and often shows molecular heterogeneity between primary lesions. Treatment decisions are particularly challenging in complex scenarios involving multiple independent lesions, distant metastasis, and advanced age with intolerance to standard chemotherapy. Case presentation: A 77-year-old man presented with hematochezia and was diagnosed with four independent neoplastic lesions within three months: a primary rectal lesion (pT3N1aM0), a sigmoid colon primary carcinoma, a proximal rectal adenoma with focal intramucosal carcinoma, and an adenocarcinoma of the transverse colon near the splenic flexure [resected by endoscopic submucosal dissection (ESD) three months later]. Bilateral hepatic metastases were detected six months postoperatively, with the carcinoembryonic antigen (CEA) level still within the reference range at diagnosis. Molecular testing of the two primary carcinomas revealed marked discordance: the primary rectal lesion carried mutation signals in both KRAS exon 4 and NRAS exon 2, whereas the sigmoid colon lesion was entirely RAS/RAF/PIK3CA wild-type — testing either lesion alone would have led to opposite anti-EGFR treatment decisions. Given the patient's advanced age and intolerance to standard chemotherapy, a staged, multimodal integrated strategy was adopted: synchronous surgery for three primary lesions, minimally invasive ESD of the transverse colon lesion, artificial ascites-assisted percutaneous microwave ablation (AA-MWA) for liver metastases, and individualized adjustment of chemotherapy (switched from CAPEOX to oxaliplatin plus raltitrexed because of intolerance). Over 18 months of follow-up, no radiological recurrence was observed and the patient remained in good general condition. Conclusions: This case demonstrates that primary lesions in SMPCRC can harbor substantial molecular heterogeneity, such that single-lesion testing may be insufficient to guide treatment decisions in complex scenarios. For elderly patients intolerant to standard regimens, a staged, multimodal integrated approach (synchronous surgery + ESD + AA-MWA + individualized chemotherapy adjustment) may serve as a feasible comprehensive treatment option.

  • Open Access

    A Multi-omics Regulated Cell Death Framework Defines Immune Phenotypes and Guides Precision Therapy in Colorectal Cancer

    by Fanhe Gao, Jun Xiang, Chunlin Wang, Hao Zhang, Yunxiao Liu, Jiaqi Wang, Hao Jiang, Nana Zhang, Nanfeng Meng, Shuaibin Feng, et al.

  • PTPN14 functions as an oncogenic promoter in colon adenocarcinoma and liver hepatocellular carcinoma via Notch Signaling

    by Yuliuming Wang, Jingtao Li, Chunlin Wang, Hao Zhang, Ziquan Sun, Zewen Chang, Yang Wang, Zhongxu Zhang, Jiaojiao Dong, Shuoran Shan, et al.

  • Open Access

    Deep learning-driven MRI radiomics reveals biological subtypes and predicts recurrence risk in rectal cancer

    by Jun Xiang, Longfei Gao, Peng Han, Fanhe Gao, Zijing Guan, Shuaibin Feng, Yunxiao Liu, Xinxin Zhang, Guiyu Wang

    Traditional TNM staging inadequately captures the recurrence risk of rectal cancer (RC), limiting prognostic accuracy and personalized treatment decisions. Here, we developed an MRI-based deep learning approach to predict recurrence risk and leveraged pathology and transcriptomic analyses to characterize tumor heterogeneity and provide biological interpretation. In this multicenter study of 2060 patients without neoadjuvant therapy across four independent cohorts (training: n = 931; internal validation: n = 365; external validation: n = 492; biological: n = 272), unsupervised clustering of deep learning-extracted radiomic features identified three biologically distinct radiomics-based deep learning subtypes (RDLSs). Comprehensive molecular profiling using single-cell RNA sequencing (n = 7), bulk RNA sequencing (n = 83), and whole-slide imaging (n = 409) revealed that RDLS1 exhibited an immune-excluded phenotype with poor prognosis, RDLS2 showed enriched lymphocyte infiltration with favorable outcomes, and RDLS3 displayed intermediate prognosis with abundant stromal elements. Multivariate Cox analysis confirmed independent prognostic value across all cohorts (RDLS2 vs. RDLS1: HR = 0.52, 95% CI: 0.29-0.82, p = 0.003). Leveraging high-risk RDLS1 features, we developed a recurrence risk scoring system (RRS) that effectively stratified patients across cohorts. Compared with the clinical model alone, integration of the RRS with clinical variables improved 5-year RFS prediction performance, increasing the AUC from 0.799 to 0.834 in the training cohort and from 0.780 to 0.825 in the external validation cohort. This noninvasive and biologically interpretable framework bridges imaging phenotypes to molecular characteristics, providing a potential approach for recurrence risk assessment and more individualized postoperative risk stratification in RC patients without neoadjuvant therapy.

  • Laparoscopic right hemicolectomy with D3 lymph node dissection and Transanal specimen extraction ( NOSES VIIIB ) in a young woman: A video vignette

    by Ziming Yuan, Yuliuming Wang, Guiyu Wang, Artur A. Ibatullin, Polina D. Panova, Niloofar Rouzy, Liu Zheng, Sergey K. Efetov, Xishan Wang

  • Open Access

    Prospective single-arm study of gastric surgery in experimental animals assisted by Kangduo surgical robot

    by Songtao Yu, Yuliuming Wang, Tianyi Ma, Tianyu Qiao, Hao Zhang, Yunxiao Liu, Chunlin Wang, Wenyang Li, Chenkai Zhang, Haonan Qi, et al.

    Objective: To investigate the feasibility, efficacy, and safety of gastric surgery in experimental animals assisted by the domestic Kangduo Surgical Robot 2000 (SR2000). Methods: Eight porcine models were prospectively enrolled between August and December 2023 at Harbin SAGEBOT Intelligent Medical Animal Experiment Center. Preoperative baseline characteristics, intraoperative physiological parameters, surgical procedure, and postoperative assessments and investigations were recorded to compare the feasibility, efficacy, and safety evaluation indexes of experimental animals in the perioperative period. The primary endpoint was surgical success rate. The secondary endpoints were operative workflow parameters, intraoperative blood loss, postoperative laboratory changes, perioperative adverse events, and surgeon workload assessed using the NASA-TLX instrument. Results: In eight experimental pig models, the SR2000 successfully assisted in the completion of partial gastrectomy. All surgeries were completed according to plan, with no intermediate open or intraoperative complications, and the perioperative survival rate of animals was 100%. The mean operation time of partial gastrectomy was 76.75 min (range: 50–105 min), and the positioning time was 6–17 min. Intraoperative bleeding was ≤5 ml in all the animals, and some animals showed elevated white blood cell counts and neutrophil counts (Neu) on the first day of the postoperative period. The liver and kidney function indexes (alanine aminotransferase, blood urea nitrogen, creatinine) were not significantly abnormal before and after surgery. The anastomosis healed well without complications such as infection and anastomotic fistula. Conclusion: The feasibility, efficacy, and safety of the SR2000 were verified in animal experiments, and ergonomically optimized design have the potential for clinical dissemination.

  • Open Access

    OSBPL3 drives colorectal cancer progression via Hippo-YAP signaling and modulates MEK inhibitor sensitivity

    by Yuchen Zhong, Chaojing Zheng, Zitong Wang, Weiyuan Zhang, Hongyu Wu, Jun Luo, Hao Zhang, Chunlin Wang, Chenkai Zhang, Hanqing Hu, et al.

    Colorectal cancer progression involves dysregulated signaling pathways such as Hippo-YAP, but upstream regulators remain poorly defined. Here we demonstrate that oxysterol-binding protein-like 3 (OSBPL3) modulates Hippo-YAP signaling to drive tumor aggressiveness. Analysis of clinical specimens and experimental models shows that elevated OSBPL3 levels in colorectal cancer tissues correlate with shortened patient survival. Depleting OSBPL3 impairs cancer cell proliferation and invasion and induces cell cycle arrest, while its overexpression accelerates tumor growth. Mechanistic studies reveal that OSBPL3 binds 14-3-3 proteins to promote YAP1 nuclear translocation, activating downstream oncogenic pathways. Notably, tumors with high OSBPL3 expression exhibit resistance to MEK inhibitors, but this resistance is overcome by YAP1 suppression or combined YAP/MEK inhibition in patient-derived organoids. These results establish OSBPL3 as a critical Hippo-YAP pathway regulator and propose targeting OSBPL3-mediated signaling as a therapeutic strategy for colorectal cancers with Hippo pathway alterations.


  • DSN1 promotes colorectal cancer metastasis by Inhibiting FZR1-Mediated ubiquitination of c-MYC

    by Chenkai Zhang, Ziming Yuan, Hanqing Hu, Chunlin Wang, Jiaqi Wang, Jun Xiang, Nana Zhang, Wenyang Li, Songtao Yu, Danil Galiullin, et al.

  • Open Access

    Lactylation-stabilized NOL6 promotes colorectal cancer progression via STAMBP-mediated YY1 deubiquitination and c-Myc transcription upregulation

    by Hao Zhang, Ye Han, Jiaqi Wang, Chunlin Wang, Zewen Chang, Jun Xiang, Hanqing Hu, Ziming Yuan, Nana Zhang, Yuliuming Wang, et al.